Arkolith/Insider Trading/EIGR/Form 4

Mayer Eldon C. III

Ex VP & Chief Commerc. OfficerEiger BioPharmaceuticals, Inc. (EIGR) · full profile →Form 4 · filed Mar 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2023Sell(S)3K$1.07$3K58K
Mar 17, 2023Sell(S)2K$1.07$2K56K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-012884) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML